3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Phase 1
1
Status
Completed
14
Active not recruiting
5
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Breast
1
Conditions
Neoplasms
85
Carcinoma, Non-Small-Cell Lung
75
Breast Neoplasms
73
Recurrence
64
Colorectal Neoplasms
62
Pancreatic Neoplasms
59
Multiple Myeloma
57
Melanoma
56
Carcinoma, Hepatocellular
56
Advanced Solid Tumor
55
Leukemia, Myeloid, Acute
53
Advanced Solid Tumors
53
Lymphoma
52
Neoplasm Metastasis
50
Stomach Neoplasms
45
Precursor Cell Lymphoblastic Leukemia-Lymphoma
44
Solid Tumor
39
Lymphoma, B-Cell
39
Ovarian Neoplasms
38
Lymphoma, Non-Hodgkin
37
Lung Neoplasms
35
Glioblastoma
35
Prostatic Neoplasms
34
Leukemia
28
Head and Neck Neoplasms
27
Leukemia, Lymphocytic, Chronic, B-Cell
26
Uterine Cervical Neoplasms
25
Burkitt Lymphoma
24
Esophageal Neoplasms
22
Urinary Bladder Neoplasms
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Unknown
×
Urethral Neoplasms
×
Clear all
NCT03934827
2022-08-11
MICROBIOME
Imperial College London
Phase 1
Unknown
120 enrolled